RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Consensus development conference on the medical treatment of non-small cell lung cancer: treatment of the early stages
2002-01-01 Scagliotti, Giorgio
COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery
2022-01-01 Bungaro M.; Passiglia F.; Scagliotti G.V.
Docetaxel-based combined-modality chemoradiotherapy for locally advanced non-small cell lung cancer
2003-01-01 Scagliotti, Giorgio V; Turrisi, Andrew T
Emerging role of thymidylate synthase for the pharmacogenomic selection of patients with thoracic cancer
2010-01-01 Ceppi P; Monica V; Righi L; Papotti M; Scagliotti GV
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies
2003-01-01 Hirsch, Fred R; Scagliotti, Giorgio V; Langer, Corey J; Varella-Garcia, Marileila; Franklin, Wilbur A
Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets
2024-01-01 Merlini, Alessandra; Rabino, Martina; Brusco, Silvia; Pavese, Valeria; Masci, Debora; Sangiolo, Dario; Bironzo, Paolo; Scagliotti, Giorgio Vittorio; Novello, Silvia; D'Ambrosio, Lorenzo
Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval
2022-01-01 Cadieux B.; Coleman R.; Jafarinasabian P.; Lipton A.; Orlowski R.Z.; Saad F.; Scagliotti G.V.; Shimizu K.; Stopeck A.
Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues.
2014-01-01 Volante M; Birocco N;Gatti G; Duregon E; lorizzo K; Fazio N; Scagliotti GV; Papotti M
First-line therapeutic options for advanced non-small-cell lung cancer in the molecular medicine era
2014-01-01 Enrica Capelletto;Silvia Novello;Giorgio V Scagliotti
Gemcitabine/cisplatin as induction therapy for stage IIIA N2 non-small-cell lung cancer
2000-01-01 Scagliotti, GV
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 03-CONTRIBUTO IN RIVISTA 65
- 03-CONTRIBUTO IN RIVISTA::03B-Rev... 65
Data di pubblicazione
- 2020 - 2024 27
- 2010 - 2019 23
- 2000 - 2009 13
- 1995 - 1999 2
Rivista
- CANCER TREATMENT REVIEWS 7
- JOURNAL OF THORACIC ONCOLOGY 7
- LUNG CANCER 6
- CRITICAL REVIEWS IN ONCOLOGY HEMA... 5
- CLINICAL LUNG CANCER 3
- FUTURE ONCOLOGY 3
- SEMINARS IN ONCOLOGY 3
- ENDOCRINE-RELATED CANCER 2
- EXPERT REVIEW OF ANTICANCER THERAPY 2
- TRANSLATIONAL LUNG CANCER RESEARCH 2
Keyword
- Humans 21
- Carcinoma 16
- Lung Neoplasms 16
- Non-Small-Cell Lung 15
- Oncology 9
- Antineoplastic Agents 7
- Antineoplastic Combined Chemother... 7
- Cisplatin 7
- Biomarkers 4
- Clinical Trials as Topic 4
Lingua
- eng 64
- ita 1
Accesso al fulltext
- reserved 30
- open 18
- no fulltext 12
- partially open 5